Sign In
Last checked at 
1 Apr 2011 10:28
For immediate release | 1 April 2011 |
Futura Medical plc
("Futura" or "the Company")
Director's Share Dealing
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that Derek Martin, the Finance Director, has gifted 50,000 ordinary shares to his wife, Julie Martin, at no cost. Separately, each of Mr and Mrs Martin has today sold 50,000 new ordinary shares in the Company at a price of 64p per share.
In a correction to the Company's announcement of 25 March 2011, the exercise price for the options was 41.75p rather than the 43p stated in the release.
Following the transactions, Mr Martin's beneficial and non-beneficial holding in ordinary shares in the Company for the purposes of the AIM Rules for Companies will be 125,000 ordinary shares, representing 0.17% of the Company's share capital.
For any further information please contact:
Futura Medical plc |
|
James Barder, Chief Executive
| Tel: +44 (0)1483 685 670 |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
|
|
Nomura Code Securities Limited |
|
Phil Walker / Giles Balleny | Tel:+44 (0)20 7776 1200 |
|
|
For media enquiries please contact: |
|
|
|
Buchanan Communications |
|
Mark Court / Jessica Fontaine | Tel: +44 (0)20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
Follow the stocks
